We also observed a significant increase in p‐Tau (Ser202, Thr205, p‐Tau) in NA‐GBM patient samples compared to unaffected control individual samples (Figure 4c,d) (p = 0.0433). The gene discussed is MAPT; the disease is glioblastoma.